In fact, increased intron retention, alternative splicing and activation of cryptic 3′ splice sites were reported in CLL samples harboring SF3B1 mutations [6, 8, 39]. This evidence concerns the gene SF3B1 and B-cell chronic lymphocytic leukemia.